Publications by authors named "M Jallow"
Objectives: Acute respiratory infections are among the leading cause of mortality in children under 5 years of age worldwide, with most of these deaths due to bronchiolitis and pneumonia. We investigated and analyzed a pediatric outbreak of acute respiratory infections that resulted in the hospitalization of four infants in a nursery in Dakar in late April 2024.
Methods: Nasopharyngeal specimens were collected from infants and tested for a panel of respiratory pathogens by multiplex real-time reverse transcription-polymerase chain reaction.
Despite decades of influenza surveillance in many African countries, little is known about the evolutionary dynamics of seasonal influenza viruses. This study aimed to characterize the epidemiological, genetic and antigenic profiles of A/H3N2 viruses in Senegal from 2010 to 2022. A/H3N2 infection was confirmed using reverse transcription-polymerase chain reaction.
View Article and Find Full Text PDFArticle Synopsis
- - The study aimed to determine the prevalence of antibodies to equine epizootic lymphangitis (EL) in horses and donkeys in rural Gambia and identify risk factors for seropositivity.
- - A total of 555 equids were tested, revealing a seroprevalence of 79.9% in horses and 46.7% in donkeys, with factors like age, sex, and season impacting these rates.
- - Two models showed that female horses and those from rainy season samples had higher odds of seropositivity, while younger horses and those involved in firewood transportation had lower odds.
Background: Computer-aided detection (CAD) systems hold promise for improving tuberculosis (TB) detection on digital chest radiographs. However, data on their performance in exclusively paediatric populations are scarce.
Methods: We conducted a retrospective diagnostic accuracy study evaluating the performance of CAD4TBv7 (Computer-Aided Detection for Tuberculosis version 7) using digital chest radiographs from well-characterised cohorts of Gambian children aged <15 years with presumed pulmonary TB.
Background: Despite Africa's significant infectious disease burden, it is underrepresented in global vaccine clinical trials. While this trend is slowly reversing, it is important to recognize and mitigate the challenges that arise when conducting vaccine clinical trials in this environment. These challenges stem from a variety of factors peculiar to the population and may negatively impact adverse event collection and reporting if not properly addressed.
View Article and Find Full Text PDF